Physician profile
Jeffrey Fox
NPI 1447216536
$1,410.69
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.26 · 2020: $89.65 · 2021: $306 · 2022: $198 · 2023: $395 · 2024: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $754.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $754.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $232.99 | 2020-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $158.55 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $155.08 | 2020-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.32 | 2021-2023 | Jardiance |
| Pfizer INC. | $139.51 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.75 | 2023-2024 | |
| Novo Nordisk INC | $82.25 | 2023-2024 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $72.06 | 2023-2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $55.52 | 2022-2023 | Quviviq |
| Abbott Laboratories | $52.58 | 2022 | |
| Phathom Pharmaceuticals, INC. | $47.79 | 2024 | Voquezna |
| Lilly USA, LLC | $45.45 | 2021-2024 | Mounjaro |
| Medtronic, INC. | $30.43 | 2024 | Intellis Adaptivestim |
| Dexcom, INC. | $29.41 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $19.24 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.53 | 2021 | |
| Amarin Pharma, INC. | $16.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.